Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

1.4K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.4K
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents01:20

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

1.3K
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
1.3K
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists01:28

Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists

1.1K
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
1.1K
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors01:13

Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors

1.0K
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
1.0K
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

577
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
577
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists01:23

Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists

1.1K
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Socioeconomic Outcomes of Childhood Cancer Survivors in India: A Cross-Sectional Study From a Tertiary Care Childhood Cancer Survivorship Program.

JCO global oncology·2026
Same author

Development of Albumin Nanocarriers for Enhanced Curcumin Delivery and In Vitro Anticancer Activity in Colon Cancer Cells.

Pharmaceuticals (Basel, Switzerland)·2026
Same author

Targeting mtDNA to Modulate Mitochondrial Dysfunction in Neurodegenerative Diseases.

Molecular neurobiology·2026
Same author

Smart sensing the spectrum: cutting-edge biosensor and biomarker approaches for early autism detection.

Metabolic brain disease·2026
Same author

Hormonal Imbalance and Gut Dysbiosis: Emerging Perspectives in Women's Health.

Probiotics and antimicrobial proteins·2026
Same author

Recent trends in anti-Alzheimer's potential of novel biologically active isatin analogues: synthetic strategies, structural activity relationship studies and molecular docking insights.

Molecular diversity·2026
Same journal

Benzothiazole Derivatives: Emerging Potential as Anti-Rheumatic Agents and other Pharmacological Effects.

Anti-inflammatory & anti-allergy agents in medicinal chemistry·2026
Same journal

Design of pH-responsive Nanocarriers for Controlled Delivery of Anti-allergic Corticosteroid Analogues.

Anti-inflammatory & anti-allergy agents in medicinal chemistry·2026
Same journal

Antifungal Efficacy of Natural Oils: A Comprehensive Review on Mechanisms and Innovations.

Anti-inflammatory & anti-allergy agents in medicinal chemistry·2026
Same journal

Design of Antiacne Gel Containing Phloretin.

Anti-inflammatory & anti-allergy agents in medicinal chemistry·2026
Same journal

Immunomodulatory Nanocarriers in Multiple Sclerosis: Dual Targeting of Microglia and Mitochondria for Precision Neurotherapy.

Anti-inflammatory & anti-allergy agents in medicinal chemistry·2026
Same journal

Integrated Virtual Screening Approaches to Identify Novel N- Substituted Heterocyclic Compounds as MAPK Inhibitors for Neuro Inflammation.

Anti-inflammatory & anti-allergy agents in medicinal chemistry·2026
See all related articles

Related Experiment Video

Updated: Feb 28, 2026

Microwave-Assisted Preparation of 1-Aryl-1H-pyrazole-5-amines
05:07

Microwave-Assisted Preparation of 1-Aryl-1H-pyrazole-5-amines

Published on: June 23, 2019

7.1K

Pyrazole Derivatives as Selective COX-2 Inhibitors: An Updated Review.

Rajarshi Nath1,2, Bikram Nandi1, Arindam Maity2

  • 1Department of Pharmaceutical Chemistry, Bharat Technology, Uluberia-711316, Howrah, West Bengal, India.

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
|February 26, 2026
PubMed
Summary
This summary is machine-generated.

New pyrazole derivatives show promise as selective cyclooxygenase-2 (COX-2) inhibitors for treating inflammation. This research reviews their synthesis and activity, offering insights for developing safer anti-inflammatory drugs.

Keywords:
COX-2 inhibitorPyrazoleinflammationstructure-activity relationship (SAR).synthesis

More Related Videos

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
05:17

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

2.1K
Synthesis of Antiviral Tetrahydrocarbazole Derivatives by Photochemical and Acid-catalyzed C-H Functionalization via Intermediate Peroxides CHIPS
06:34

Synthesis of Antiviral Tetrahydrocarbazole Derivatives by Photochemical and Acid-catalyzed C-H Functionalization via Intermediate Peroxides CHIPS

Published on: June 20, 2014

14.4K

Related Experiment Videos

Last Updated: Feb 28, 2026

Microwave-Assisted Preparation of 1-Aryl-1H-pyrazole-5-amines
05:07

Microwave-Assisted Preparation of 1-Aryl-1H-pyrazole-5-amines

Published on: June 23, 2019

7.1K
Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
05:17

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

2.1K
Synthesis of Antiviral Tetrahydrocarbazole Derivatives by Photochemical and Acid-catalyzed C-H Functionalization via Intermediate Peroxides CHIPS
06:34

Synthesis of Antiviral Tetrahydrocarbazole Derivatives by Photochemical and Acid-catalyzed C-H Functionalization via Intermediate Peroxides CHIPS

Published on: June 20, 2014

14.4K

Area of Science:

  • Medicinal Chemistry
  • Drug Discovery
  • Pharmacology

Background:

  • Inflammation is a key factor in numerous chronic diseases, driving the need for effective anti-inflammatory drugs.
  • Current non-steroidal anti-inflammatory drugs (NSAIDs) carry risks of adverse reactions, particularly gastrointestinal issues, due to nonselective cyclooxygenase (COX) inhibition.
  • Targeting the inducible COX-2 enzyme offers a strategy for developing anti-inflammatory agents with improved safety profiles.

Purpose of the Study:

  • To provide a comprehensive overview of novel pyrazole derivatives synthesized in the last five years.
  • To evaluate the inhibitory activity of these pyrazole derivatives against COX-2.
  • To explore the structure-activity relationships (SAR) and docking insights for next-generation COX-2 inhibitor development.

Main Methods:

  • Literature review focusing on pyrazole derivative synthesis and COX-2 inhibitory activity from the past 5 years.
  • Analysis of structure-activity relationships (SAR) of identified compounds.
  • In silico docking studies to understand binding interactions with the COX-2 enzyme.

Main Results:

  • Identification of various pyrazole derivatives with significant COX-2 inhibitory potential.
  • Elucidation of key structural features contributing to COX-2 selectivity and potency.
  • Demonstration of the utility of pyrazole scaffolds in designing effective COX-2 inhibitors.

Conclusions:

  • Pyrazole derivatives represent a promising class of compounds for the development of novel, selective COX-2 inhibitors.
  • The reviewed SAR and docking data can guide medicinal chemists in designing next-generation anti-inflammatory drugs.
  • Further research into pyrazole-based compounds could lead to safer and more effective treatments for inflammatory conditions.